Financhill
Back

Passage Bio, Inc. Stock Predictions

Passage Bio, Inc. Stock Forecast

  • Over the next 52 weeks, Passage Bio, Inc. has on average historically fallen by 42% based on the past 5 years of stock performance.
  • Passage Bio, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is Passage Bio, Inc. Stock Undervalued?
    The current Passage Bio, Inc. [PASG] share price is $9.80. The Score for PASG is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • PASG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Passage Bio, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Passage Bio, Inc. has on average historically fallen by 42% based on the past 5 years of stock performance.

Passage Bio, Inc. Stock Rating

Buy
67
Passage Bio, Inc. (PASG) is a Buy

Is Passage Bio, Inc. overpriced?

  • Passage Bio, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Passage Bio, Inc. Stock Price History

Is PASG stock going to rise?

  • The current trend is moderately bullish and PASG is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
passagebio.com

52-Week Data

52-Week High:
20.20
52-Week Low:
5.12

Prediction Charts

Market Cap:
30.6M
Price in USD:
9.80
Volume:
77.4K
Beta:
1.62

Technical Analysis

SMA50:
8.27
SMA100:
7.62
SMA200:
7.61
52-Wk Change:
-37.46%

Stock Predictions

  • Is Passage Bio, Inc. stock public?
    Yes, Passage Bio, Inc. is a publicly traded company.
  • What is the Passage Bio, Inc. stock quote today?
    The Passage Bio, Inc. stock price is 9.80 USD today.
  • How to buy Passage Bio, Inc. stock online?
    You can buy Passage Bio, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-24 8.08 8.56 8.75 7.61
Nov-25 8.52 8.98 9.12 8.13
Nov-26 8.94 8.99 9.02 8.36
Nov-28 8.60 8.83 9.20 8.47
Dec-1 8.59 8.22 9.03 8.04
Dec-2 8.34 8.03 8.90 7.59
Dec-3 8.05 8.59 8.60 8.00
Dec-4 8.56 9.18 9.18 8.25
Dec-5 9.13 9.21 9.31 8.23
Dec-8 9.25 9.92 10.25 9.13
Dec-9 9.86 10.40 10.61 9.86
Dec-10 10.32 10.41 10.50 9.90
Dec-11 10.41 10.68 10.71 9.96
Dec-12 10.50 9.80 10.57 9.72

Passage Bio, Inc. Earnings

Passage Bio, Inc. Earnings Report: Per Share Passage Bio, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Passage Bio, Inc. Forecast Revenue Growth

Passage Bio, Inc. Stock Analysis: Historical quarterly revenues per share for Passage Bio, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.33 per share, and an increase next year of $4.79 per share.

* Passage Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.